Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration
التفاصيل البيبلوغرافية
العنوان:
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration
RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, Pulmonary Medicine
المصدر:
Annals of oncology, vol. 30, no. 11, pp. 1686-1688, 2019. Annals of Oncology, 30(11), 1686-1688. Oxford University Press Annals of Oncology, 30(11), 1686-1688. Elsevier Ltd.